-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Present value of lessee's discounted obligation for lease payments from operating lease.
-
Summary
-
Ambrx Biopharma Cayman, Inc. quarterly Operating Lease, Liability history and growth rate from Q4 2021 to Q4 2022.
- Ambrx Biopharma Cayman, Inc. Operating Lease, Liability for the quarter ending December 31, 2022 was $12M, a 8.75% decline year-over-year.
Operating Lease, Liability, Quarterly (USD)
Operating Lease, Liability, YoY Quarterly Growth (%)